Eurizon Capital SGR S.p.A. Takes $34.78 Million Position in McKesson Corporation $MCK

Eurizon Capital SGR S.p.A. purchased a new stake in shares of McKesson Corporation (NYSE:MCK) during the 4th quarter, Holdings Channel.com reports. The fund purchased 42,397 shares of the company’s stock, valued at approximately $34,783,000.

Several other hedge funds have also modified their holdings of the stock. Fideuram Asset Management Ireland dac bought a new stake in shares of McKesson during the fourth quarter valued at approximately $1,162,000. Marshall & Sterling Wealth Advisors Inc. bought a new stake in shares of McKesson during the fourth quarter valued at approximately $295,000. Principia Wealth Advisory LLC grew its stake in shares of McKesson by 155.1% during the fourth quarter. Principia Wealth Advisory LLC now owns 176 shares of the company’s stock valued at $144,000 after purchasing an additional 107 shares during the last quarter. National Pension Service lifted its holdings in McKesson by 2.5% in the fourth quarter. National Pension Service now owns 397,064 shares of the company’s stock valued at $325,708,000 after buying an additional 9,608 shares during the period. Finally, Rothschild Investment LLC lifted its holdings in McKesson by 11.2% in the fourth quarter. Rothschild Investment LLC now owns 438 shares of the company’s stock valued at $359,000 after buying an additional 44 shares during the period. 85.07% of the stock is owned by institutional investors.

Insiders Place Their Bets

In related news, EVP Michele Lau sold 3,550 shares of the firm’s stock in a transaction on Tuesday, May 26th. The shares were sold at an average price of $761.09, for a total transaction of $2,701,869.50. Following the sale, the executive vice president directly owned 3,247 shares in the company, valued at $2,471,259.23. This trade represents a 52.23% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Thomas L. Rodgers sold 2,388 shares of the firm’s stock in a transaction on Tuesday, May 26th. The stock was sold at an average price of $761.09, for a total transaction of $1,817,482.92. Following the sale, the executive vice president owned 3,090 shares in the company, valued at approximately $2,351,768.10. The trade was a 43.59% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last 90 days, insiders have sold 8,663 shares of company stock worth $7,217,102. 0.08% of the stock is currently owned by company insiders.

McKesson Stock Performance

MCK opened at $741.47 on Friday. The firm’s fifty day moving average is $819.93 and its two-hundred day moving average is $852.44. The firm has a market cap of $89.12 billion, a PE ratio of 19.27, a price-to-earnings-growth ratio of 1.11 and a beta of 0.35. McKesson Corporation has a twelve month low of $637.00 and a twelve month high of $999.00.

McKesson (NYSE:MCK) last posted its earnings results on Thursday, May 7th. The company reported $11.69 earnings per share for the quarter, topping the consensus estimate of $11.56 by $0.13. The company had revenue of $96.30 billion for the quarter, compared to analyst estimates of $101.35 billion. McKesson had a net margin of 1.18% and a negative return on equity of 345.35%. The business’s revenue for the quarter was up 6.0% compared to the same quarter last year. During the same period last year, the business posted $10.12 earnings per share. McKesson has set its FY 2027 guidance at 43.800-44.600 EPS. Equities analysts forecast that McKesson Corporation will post 44.29 EPS for the current fiscal year.

McKesson Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 1st. Investors of record on Monday, June 1st will be issued a dividend of $0.82 per share. This represents a $3.28 dividend on an annualized basis and a dividend yield of 0.4%. The ex-dividend date is Monday, June 1st. McKesson’s dividend payout ratio (DPR) is presently 8.53%.

Analyst Upgrades and Downgrades

MCK has been the topic of several analyst reports. UBS Group increased their price objective on shares of McKesson from $1,000.00 to $1,050.00 and gave the company a “buy” rating in a report on Friday, May 8th. Citigroup cut their price objective on shares of McKesson from $975.00 to $945.00 and set a “buy” rating on the stock in a report on Thursday, May 14th. Evercore restated an “outperform” rating on shares of McKesson in a report on Thursday, March 5th. Barclays increased their price objective on shares of McKesson from $960.00 to $1,050.00 and gave the company an “overweight” rating in a report on Wednesday, February 18th. Finally, Raymond James Financial set a $970.00 price objective on shares of McKesson in a report on Thursday, March 5th. Fourteen equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $968.87.

McKesson Company Profile

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.